Developing a donation after cardiac death risk index for adult and pediatric liver transplantation

Table 1 Summary of the descriptive statistics for donor (d) and the recipient (r) that form the study donor after cardiac death cohort from which the donor after cardiac death risk index score was developed

DCD donor and recipient variables			All (n = 261)
Donor	dAge (yr)		46.1 ± 17.9
	dBMI		26 ± 4.9
	ITU Stay (d)		3.9 ± 5.8
	COD (CVA: Other: HBI: Trauma)		52.5:13.8:16.9:16.9
	dSodium (mmol/L)		144.51 ± 11.8
	dBilirubin (μmol/L)		9.81 ± 6.88
	Split/reduced (%)		2.30%
	WIT (min)		16.7 ± 9.8
	dHepT (min)		24.3 ± 10.6
	Liver Weight (g)		1518.28 ± 397.507
	CIT (min)		431 ± 118
Recipient	rAge (yr)		49.45 ± 15.36
	rGender		70.1%M/39.9%F
	rBMI		25.9 ± 4.7
	ALF (%)		1.50%
	rBilirubin (mmol/L)		89.36 ± 116.38
	rINR		1.89 ± 1.88
	MELD		14.8 ± 6.4
	Location (inpatient/home)		20.3%/79.6%
	Prior abdominal surgery (yr)		13.40%
	reTPL (yr)		5.70%
	Indication for TPL	Low	68 (26%)
		Standard	176 (67.5%)
		High	17 (6.5%)

Data presented as mean ± SD or % where appropriate. Primary indication for transplant has been divided into three risk groups of low, standard and high risk, as defined by their survival curves. BMI: Body mass index; COD: Cause of death; CVA: Cerebrovascular accident; HBI: Hypoxic brain injury; WIT: Warm ischemic time; CIT: Cold ischemic time; dHepT: Donor hepatectomy time; ALF: Acute liver failure; MELD: Model for end stage liver disease; reTPL: Retransplantation; TPL: Transplant.